You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 2, February 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  TODAY'S PRACTICE OF MEDICINE
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mild Hypertension

When and How to Treat

Norman M. Kaplan, MD

Arch Intern Med. 1983;143(2):255-259.


Abstract

• "Early and aggressive" drug therapy for mild hypertension, now widely prescribed in the United States, may be inappropriate for many of the 30 million patients with this condition. Although all of these patients are at greater risks of premature cardiovascular disease, the risks are manifested neither quickly nor uniformly. Drug therapy has not proved beneficial for patients with a diastolic (D) BP reading below 100 mm Hg, particularly those patients who are otherwise at low risk. Those antihypertensive drugs that are available now carry risks along with their benefits. Therefore, persons with mild hypertension who are at low risk should be encouraged to use nondrug therapies for at least six to 12 months. If their DBP remains below 100 mm Hg, they may be better off than if they were given drugs. The drug used in initial therapy has usually been a diuretic. For many patients, however, an adrenergic inhibitor may be a more appropriate choice.

(Arch Intern Med 1983;143:255-259)



Author Affiliations

From the Health Science Center, University of Texas at Dallas.


Footnotes

Accepted for publication Aug 2, 1982.

Reprint requests to the Health Science Center, University of Texas at Dallas, 5323 Harry Hines Blvd, Dallas TX 75235 (Dr Kaplan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Science, Ethics, and the Making of Clinical Decisions: Implications for Risk Factor Intervention
Forrow et al.
JAMA 1988;259:3161-3167.
ABSTRACT  

The Need to Treat Mild Hypertension: Misinterpretation of Results From the Australian Trial
Abernethy
JAMA 1986;256:3134-3137.
ABSTRACT  

Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men
CASALE et al.
ANN INTERN MED 1986;105:173-178.
ABSTRACT  

Non-Drug Treatment of Hypertension
KAPLAN
ANN INTERN MED 1985;102:359-373.
ABSTRACT  

Excessive Doses of Drugs
Finucane and D'Alessandri
JAMA 1984;252:1685-1685.
ABSTRACT  

Sustained Improvement in Drug Documentation, Compliance, and Disease Control: A Four-Year Analysis of an Ambulatory Care Model
Bond and Monson
Arch Intern Med 1984;144:1159-1162.
ABSTRACT  

Clinical Trials, Diuretics, and the Management of Mild Hypertension
Moser
Arch Intern Med 1984;144:789-792.
ABSTRACT  

Nutritional Factors and Blood Pressure Control: An Assessment
CALLAWAY
ANN INTERN MED 1983;98:884-890.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.